No podrás conectarte si excedes diez intentos fallidos.
La Agencia SINC ofrece servicios diferentes dependiendo de tu perfil.
Selecciona el tuyo:
Fuente: Nutrition Metabolism and Cardiovascilar Diseases 22 [3] Marzo 2012 DOI: 10.1016/j.numecd.2010.06.002
Primer autor: Codoner-Franch, P
Centro: Hospital Universitario, Departamento de Pediatría, Valencia, España.
Título: Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children
Background and aims: The assessment of oxidative stress may aid in the identification of subsequent metabolic risk in obese children. The objective of this study was to determine whether the plasma level of advanced oxidation protein products, analyzed with a recently proposed modified assay that involves a delipidation step (mAOPPs), was related to metabolic risk factors (MRFs) in severely obese children.
Methods and results: The plasma levels of mAOPPs were determined by spectrophotometry in 54 severely obese and 44 healthy children. We also measured lipid peroxidation biomarkers (thiobarbituric acid-reactive substances, malondialdehyde, and 8-isoprotane F-2 alpha) and sulfhydryl groups, a marker of antioxidant defense. Protein oxidation and lipid peroxidation markers were higher and sulfhydryl levels were lower in obese children compared with controls. Taking metabolic risk into account, obese children were subdivided according to the cutoff point (53.2 mu mol/L) obtained for their mAOPPs values from the ROC curve. Anthropometric measures and the existence of hypertension did not differ between groups. The presence of dyslipidemia and insulin resistance was significantly higher in the group with higher mAOPPs levels. The highest levels of mAOPPs were found in the children with >= 3 MRFs. The level of mAOPPs was positively correlated with triglycerides and negatively correlated with high-density lipoprotein cholesterol. There was no correlation of this marker of protein oxidation with biomarkers of lipid peroxidation.
Autores : Codoner-Franch, P.; Tavarez-Alonso, S.; Murria-Estal, R.; Tortajada-Girbes, M.; Simo-Jorda, R; Alonso-Iglesias, E.
Direcciones :
1. Hospital Universitario, Departamento de Pediatría, Valencia, España.
2. Universidad de Valencia, Departamento de Pediatría Obstetrícia y Ginecología, Valencia, España
3. Hospital Universitario, Laboratorio de Bioquímica Clínica, Valencia, España.
4. Universidad de Valencia, Departamento de Pediatría Obstetrícia y Ginecología, Valencia, España
Si eres periodista y quieres el contacto con los investigadores, regístrate en SINC como periodista.